Australia’s Avita Raises Cash For Phase III ReCell Trials For Skin Culture Technology
This article was originally published in PharmAsia News
Executive Summary
Australia’s Avita Medical received funding from private investors and the U.S. military for a skin culture technology treatment aimed at treating wounds and burns as well as sores developed by bed-ridden patients.